Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Fatigue and Alk[original query]
A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jun 19 (11): 3068-77.
Socinski Mark A, Goldman Jonathan, El-Hariry Iman, Koczywas Marianna, Vukovic Vojo, Horn Leora, Paschold Eugene, Salgia Ravi, West Howard, Sequist Lecia V, Bonomi Philip, Brahmer Julie, Chen Lin-Chi, Sandler Alan, Belani Chandra P, Webb Timothy, Harper Harry, Huberman Mark, Ramalingam Suresh, Wong Kwok-Kin, Teofilovici Florentina, Guo Wei, Shapiro Geoffrey
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar .
Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy.
Clinical lung cancer 2017 1 18 (4): 388-395.e4.
Labbé Catherine, Leung Yvonne, Silva Lemes João Gabriel, Stewart Erin, Brown Catherine, Cosio Andrea Perez, Doherty Mark, O'Kane Grainne M, Patel Devalben, Cheng Nicholas, Liang Mindy, Gill Gursharan, Rett Alexandra, Naik Hiten, Eng Lawson, Mittmann Nicole, Leighl Natasha B, Bradbury Penelope A, Shepherd Frances A, Xu Wei, Liu Geoffrey, Howell Dor
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ?75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.
Translational lung cancer research 2020 7 9 (3): 459-470.
Kozuki Toshiyuki, Nogami Naoyuki, Hataji Osamu, Tsunezuka Yoshio, Seki Nobuhiko, Harada Toshiyuki, Fujimoto Nobukazu, Bessho Akihiro, Takamura Kei, Takahashi Kazuhisa, Satouchi Miyako, Kato Terufumi, Shukuya Takehito, Yamashita Natsumi, Okamoto Hiroaki, Shinkai Tetsu,
Evaluation of the efficacy of PD?1/PD?L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene?negative advanced?stage lung adenocarcinoma: A retrospective cohort study.
Oncology letters 2024 11 29 (1): 53.
Xiaozun Yang, Xin Li, Ke Huang, Xiang Zhua
TOP